The early psychosis intervention programme in Singapore: A balanced scorecard approach to quality care

Journal of Mental Health

Volumn 17, Issue 1, 2008, Pages 79-91

  Chong, Siow Ann ^a   Verma, Swapna ^a   Mythily, S ^a   Poon, Lye Yin ^a   McGorry, Patrick D ^b  

^a INSTITUTE OF MENTAL HEALTH   (Singapore)

^b ORYGEN RESEARCH CENTRE   (Australia)

Author keywords

Case management; Duration of untreated psychosis; Patient centred; Primary healthcare providers

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; DESCRIPTIVE RESEARCH; DISEASE DURATION; EARLY DIAGNOSIS; FEMALE; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT REFERRAL; PRESCRIPTION; PROGRAM DEVELOPMENT; PSYCHOLOGICAL MODEL; PSYCHOSIS; SINGAPORE; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 39049116161     PISSN: 09638237     EISSN: 13600567     Source Type: Journal    
DOI: 10.1080/09638230701530200     Document Type: Article

References (29)

1. Berto, P., D'Ilario, D., Ruffo, P., Di Virgilio, R., & Rizzo, F. (2000). Depression: Cost of illness studies in the international literature: A review. The Journal of Mental Health Policy and Economics, 3, 3-10.
2. Bertolote, J., & McGorry, P. (2005). Early intervention and recovery for young people with early psychosis: consensus statement. British Journal of Psychiatry Supplement, 48, s116-119.
3. Chong, S. A., Mythily, S., Lum, A., Chan, Y. H., & McGorry, P. D. (2005a). Determinants of duration of untreated psychosis and the pathway to care in Singapore. International Journal of Social Psychiatry, 51, 55-62.
4. Chong, S. A., Mythily, S., & Verma, S. (2005b). Reducing the duration of untreated psychosis and changing help-seeking behaviour in Singapore. Social Psychiatry and Psychiatric Epidemiology, 40, 619-621.
5. Chong, S. A., Ravichandran, N., Poon, L. Y., Soo, K. L., & Verma, S. (2006). Reducing polypharmacy through the introduction of a treatment algorithm: Use of a treatment on the impact on polypharmacy. Annals Academy of Medicine Singapore, 35, 457-460.
6. Gupta, S., Andreasen, N. C., Arndt, S., Flaum, M., Hubbard, W. C., & Ziebell, S. (1997). The Iowa Longitudinal Study of Recent Onset Psychosis: One-year follow-up of first episode patients. Schizophrenia Research, 23, 1-13.
7. Helgason, L. (1990). Twenty years' follow-up of first psychiatric presentation for schizophrenia: What could have been prevented? Acta Psychiatrica Scandinavica, 81, 231-235.
8. Johnstone, E. C., Crow, T. J., Johnson, A. L., & MacMillan, J. F. (1986). The Northwick Park Study of first episodes of schizophrenia. Presentation of the illness and problems relating to admission. British Journal of Psychiatry, 148, 115-120.
9. Kaplan, R. S., & Norton, D. P. (1996). The Balanced Scorecard. Boston, MA: Harvard Business School Press.
10. Kay, S. R., Fiszbein, A., & Opler, L. A. (1987). The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13, 261-276.
11. Larsen, D. L., Attkisson, C. C., Hargreaves, W. A., & Nguyen, T. D. (1979). Assessment of client/patient satisfaction: Development of a general scale. Evaluation and Program Planning, 2, 197-207.
12. Larsen, T. K., Johannessen, J. O., & Opjordsmoen, S. (1998). First-episode schizophrenia with long duration of untreated psychosis. British Journal of Psychiatry, 172 (Suppl. 33), 45-52.
13. Lieberman, J. A., & Fenton, W. S. (2000). Delayed detection of psychosis: causes, consequences, and effect on public health. American Journal of Psychiatry, 157, 1727-1730.
14. Malla, A., Norman, T., McLean, T., Scholten, D., & Townsend, L. (2003). A Canadian programme for early intervention in non-affective psychotic disorders. Australian and New Zealand Journal of Psychiatry, 37, 407-413.
15. McGlashan, T. H. (1999). Duration of untreated psychosis in first-episode schizophrenia: Marker or determinant of course? Biological Psychiatry, 46, 899-907.
16. McGorry, P. D., & Jackson, H. J. (Eds.) (1999). The recognition and management of early psychosis: A preventive approach. Cambridge: Cambridge University Press.
17. Meliones, J. (2000). Saving money, saving lives. Harvard Business Review, 78, 57-62.
18. Mihalopoulos, C., McGorry, P. D., & Carter, R. C. (1999). Is phase-specific, community-oriented treatment of early psychosis an economically viable method of improving outcome? Acta Psychiatrica Scandinavica, 100, 47-55.
19. Ministry of Health (2003). MOH Clinical Practice Guidelines. Singapore: Ministry of Health.
20. NHS Executive (1996). Burdens of disease: A discussion document. NHS Executive, Department of Health UK. London: Department of Health.
21. Perkins, D. O., Gu, H., Boteva, K., & Lieberman, J. A. (2005). Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: A critical review and meta-analysis. American Journal of Psychiatry, 162, 1785-1804.
22. Piersma, H. L., & Boes, J. L. (1997). The GAF and psychiatric outcome: A descriptive report. Community Mental Health Journal, 33, 35-41.
23. Rimar, S., & Garstka, S. J. (1999). The "Balanced Scorecard": Development and implementation in an academic clinical department. Academic Medicine, 74, 114-122.
24. Rössler, W., Salize, H. J., van Os, J., & Riecher-Rössler, A. (2005). Size of burden of schizophrenia and psychotic disorders. European Neuropsychopharmacology, 15, 399-409.
25. Santiago, J. M. (1999). Use of the Balanced Scorecard to improve the quality of behavioral health care. Psychiatric Services, 50, 1571-1576.
26. Sim, K., Su, A., Fujii, S., Yang, S. Y., Chong, M. Y., Ungvari, G. S., Si, T., Chung, E. K., Tsang, H. Y., Chan, Y. H., Heckers, S., Shinfuku, N., & Tan, C. H. (2004). Antipsychotic polypharmacy in patients with schizophrenia: A multicentre comparative study in East Asia. British Journal of Clinical Pharmacology, 58, 178-183.
27. Stewart, M. (2001). Towards a global definition of patient centred care. British Medical Journal, 322, 444-445.
28. Tapp, A., Wood, A. E., Secrest, L., Erdmann, J., Cubberley, L., & Kilzieh, N. (2003). Combination antipsychotic therapy in clinical practice. Psychiatric Services, 58, 78-183.
29. Verma, S. K., Mythily, S., Chong, S. A., & Kua, E. H. (2002). Substance abuse in schizophrenia: A Singapore perspective. Social Psychiatry and Psychiatric Epidemiology, 37, 326-328.